Research Article| Volume 57, ISSUE 2, P225-229, February 1965

Download started.


Dextran in the treatment of thrombophlebitis

      This paper is only available as a PDF. To read, Please Download here.


      In this study, dextran, when used early in the course of thromophlebitis appears to be an effective treatment. In the dosage range used here, there were no untoward reactions. The drug is easily administered, requires minimal laboratory control, and avoids the potential hazards of conventional anticoagulant therapy. Work by many investigators has shown dextran to be effective in increasing capillary-bed flow. We think that this study supports this thesis. The exact mechanism by which dextran brings these changes about is unknown, but by increasing suspension stability of red cells, dextran may prevent sludging or thrombosis at the capillary level.
      Evidence presented by chemical changes in the blood suggests that there is capillarybed stasis; the associated arterial spasm is well documented by the plethysmographic changes. These tests constitute the most clearly objective evidence available for confirming a clinical diagnosis of thrombophlebitis. There is no evidence available that dextran is a thrombolytic agent, and the data presented upon patients with thrombophlebitis of longer duration than 48 hours confirms this.
      No attempt has been made to compare dextran with other forms of therapy for thrombophlebitis. Further investigations will ultimately determine the role of this drug in thrombophlebitis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Anlyan W.G.
        • Hart D.
        Special problems in venous thrombo-embolism.
        Ann. Surg. 1957; 146: 499
        • Bernstein E.F.
        • Evans R.L.
        Low molecular weight dextran.
        J. A. M. A. 1960; 174: 1417
        • Bryant M.F.
        • Bloom W.L.
        • Brewer S.S.
        Use of dextran in preventing thrombosis of small arteries following surgical trauma.
        J. M. A. Georgia. 1961; 50: 580
        • Coon W.W.
        • Coller F.A.
        Clinicopathological correlation of thrombo-embolism.
        Surg. Gynec. & Obst. 1959; 109: 259
        • De Bakey M.E.
        A critical evaluation of the problem of thrombo-embolism.
        Internat. Abst. Surg. 1954; 98: 1
        • Flotte C.T.
        • Cox E.F.
        Dextran in the treatment of thrombophlebitis.
        Tr. South. S. A. 1963; 74
        • Gelin L.E.
        • Ingelman B.
        Rheomacrodex, a new dextran solution for rheological treatment of impaired capillary flow.
        Acta chir. scandinav. 1961; 122: 294
        • Gelin L.E.
        • Zederfeldt B.
        Experimental evidence of the significance of disturbances in the flow properties of blood.
        Acta chir. scandinav. 1961; 122: 336
        • Knisely M.H.
        An annotated bibliography on sludged blood.
        Postgrad. Med. 1951; 10: 15
        • Thorsen G.
        The use of dextrans as infusion fluids.
        Surg. Gynec. & Obst. 1959; 109: 43
        • Virchow R.
        Thrombose und Embolie (1846–1856). Klassiker der Medizin, herausgegeben von Karl Sudhoff.
        in: Verlag von Johann Ambrosius Barth, Leipzig1910: 21 (chap. 2)